Acute myeloid leukaemia (in remission) Recruiting Phase 1 Trials for Fludarabine (DB01073)

Also known as: Acute Myeloid Leukemia in Remission / Acute myeloid leukemia (in remission) / Acute myeloblastic leukemia, in remission / Acute myeloid leukaemia in remission

IndicationStatusPhase
DBCOND0006975 (Acute myeloid leukaemia (in remission))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01619761NK Cells in Cord Blood TransplantationTreatment
NCT02960646Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment
NCT03494569Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic SyndromeTreatment